Synthesis and functional activity of (2-aryl-1-piperazinyl)-N-(3-methylphenyl)acetamides: selective dopamine D4 receptor agonists
- 1 July 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 12 (13) , 3471-3483
- https://doi.org/10.1016/j.bmc.2004.04.035
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Design, Synthesis, and Evaluation of Matrix Metalloprotease Inhibitors Bearing Cyclopropane-Derived Peptidomimetics as P1‘ and P2‘ ReplacementsThe Journal of Organic Chemistry, 2002
- Dopamine receptors—physiological understanding to therapeutic intervention potentialPharmacology & Therapeutics, 1999
- D4/5-HT2A Receptor antagonists: LU-111995 and other potential new antipsychotics in developmentDrugs of the Future, 1998
- Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonistTrends in Pharmacological Sciences, 1997
- Repeat sequences in the gene encoding the human D4 dopamine receptorGene, 1992
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- Molecular cloning and expression of the gene for a human D1 dopamine receptorNature, 1990
- Multiple receptors for dopamineNature, 1979
- Rapid chromatographic technique for preparative separations with moderate resolutionThe Journal of Organic Chemistry, 1978
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973